この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2021/5/281 分で読めます
Revocation of Authorization of Emergency Use of a Medical Device During COVID-19; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to Battelle Memorial Institute for the Battelle Critical Care Decontamination System. FDA revoked the Authorization on April 30, 2021, under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as requested by Battelle Memorial Institute on April 2, 2021. The revocation, which includes an explanation of the reasons for the revocation, is reprinted in this document.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →